Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1307
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03586453 | Osimertinib In EGFR Mutant Lung Cancer | ||
| NCT06803875 | Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma | ||
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | ||
| NCT06518564 | Avelumab and M1774 in ARID1A-mutated Endometrial Cancer | ||
| NCT01844999 | Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks | ||
| NCT06654466 | Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer | ||
| NCT01747551 | FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer | ||
| NCT02912572 | Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer | ||
| NCT00361244 | SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer | ||
| NCT01339039 | Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma | ||
| NCT00392665 | Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00020670 | Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia | ||
| NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | ||
| NCT01853345 | iCAT for Recurrent/Refractory/HR Solid Tumors | ||
| NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | ||
| NCT03351803 | BRCA Founder OutReach (BFOR) Study | ||
| NCT00047294 | Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT03576872 | The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients | ||
| NCT01750762 | Lenalidomide After Allo Transplant | ||
| NCT00782626 | Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas | ||
| NCT03289676 | Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV | ||
| NCT00268918 | Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients | ||
| NCT00749320 | Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC) | ||
| NCT00601120 | RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma | ||
| NCT02871791 | Palbociclib With Everolimus + Exemestane In BC | ||
| NCT00585507 | Efficacy and Safety of 500mg of Fulvestrant | ||
| NCT06483139 | Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy | ||
| NCT00317603 | Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients | ||
| NCT01659203 | Proton or Photon RT for Retroperitoneal Sarcomas | ||
| NCT03310879 | Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6 | ||
| NCT03865654 | Individualizing Surveillance Mammography for Older Breast Cancer Survivors | ||
| NCT00512850 | Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps | ||
| NCT00137774 | Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors | ||
| NCT02158091 | A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL | ||
| NCT02257541 | BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) | ||
| NCT00903162 | Extended Endocrine Therapy for Premenopausal Women With Breast Cancer | ||
| NCT06202183 | Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial | ||
| NCT02752061 | Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care | ||
| NCT02787369 | ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL | ||
| NCT05080166 | UPLYFT For Lymphoma Survivors | ||
| NCT03534323 | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS | ||
| NCT03782064 | Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma | ||
| NCT02950987 | Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes | ||
| NCT02041325 | Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias | ||
| NCT01550458 | Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers | ||
| NCT01983410 | A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma | ||
| NCT00684411 | Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT06152809 | CIML NK Cells With Venetoclax for AML | ||
| NCT00165399 | Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment |
